日水製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2013/03/15 | 日証協 | 59,600株 | +16.18% | 151,800株 | +61.32% | 85,467株 | +25.56% | 11,600株 | -11.46% |
2013/03/08 | 日証協 | 51,300株 | +3.22% | 94,100株 | -20.66% | 68,067株 | +4.45% | 13,101株 | +172.94% |
2013/03/01 | 日証協 | 49,700株 | +2.69% | 118,600株 | -21.97% | 65,166株 | +2.36% | 4,800株 | +99.67% |
2013/02/22 | 日証協 | 48,400株 | +60.8% | 152,000株 | +127.89% | 63,666株 | +28.98% | 2,404株 | -85.86% |
2013/02/15 | 日証協 | 30,100株 | +1.35% | 66,700株 | -5.79% | 49,362株 | -0.2% | 17,000株 | +233.33% |
2013/02/08 | 日証協 | 29,700株 | +10.41% | 70,800株 | -22.37% | 49,462株 | +5.77% | 5,100株 | +13.33% |
2013/02/01 | 日証協 | 26,900株 | +40.84% | 91,200株 | +56.7% | 46,762株 | +6.36% | 4,500株 | +350% |
2013/01/25 | 日証協 | 19,100株 | -15.86% | 58,200株 | +162.16% | 43,967株 | -5.79% | 1,000株 | -91.08% |
2013/01/18 | 日証協 | 22,700株 | +26.82% | 22,200株 | -50.56% | 46,668株 | +13.13% | 11,215株 | +128.5% |
2013/01/11 | 日証協 | 17,900株 | +113.1% | 44,900株 | +454.32% | 41,253株 | +9.58% | 4,908株 | +145.4% |
2013/01/04 | 日証協 | 8,400株 | +2.44% | 8,100株 | -37.69% | 37,647株 | -2.59% | 2,000株 | +42.76% |
2012/12/28 | 日証協 | 8,200株 | +18.84% | 13,000株 | -42.73% | 38,647株 | -12.66% | 1,401株 | +40.1% |
2012/12/21 | 日証協 | 6,900株 | +25.45% | 22,700株 | +55.48% | 44,247株 | 0% | 1,000株 | -62.96% |
2012/12/14 | 日証協 | 5,500株 | -11.29% | 14,600株 | +20.66% | 44,247株 | -6.94% | 2,700株 | +1243.28% |
2012/12/07 | 日証協 | 6,200株 | +14.81% | 12,100株 | +92.06% | 47,548株 | -3.45% | 201株 | -89.42% |
2012/11/30 | 日証協 | 5,400株 | +54.29% | 6,300株 | +113.85% | 49,247株 | 0% | 1,900株 | +850% |
2012/11/22 | 日証協 | 3,500株 | 0% | 2,946株 | +29.1% | 49,247株 | -1.79% | 200株 | -81.82% |
2012/11/16 | 日証協 | 3,500株 | +17.37% | 2,282株 | -3.47% | 50,147株 | -12.37% | 1,100株 | -83.08% |
2012/11/09 | 日証協 | 2,982株 | -11.83% | 2,364株 | -22.85% | 57,229株 | +8.33% | 6,500株 | +22.64% |
※株式分割は考慮していませんのでご注意ください。